Connect with us

National

Moderna becomes first to start trialing Covid-19 jab on kids aged 6 months to 11 years – RT

US pharmaceutical firm Moderna has commenced trials of its Covid-19 vaccine on kids ranging from just 6 months to 11 years old, the youngest so far to receive any…

Published

on

Article feature image

On Tuesday, Moderna announced it had given the first doses of its jab to children in the Phase 2/3 trial, called the KidCOVE study. The trial, in partnership with the National Institutes of Health (NIH), intends to recruit 6,750 children, aged between 6 months and less than 12 years. 
In December, Moderna commenced a study of its coronavirus vaccine on adolescents, aged 12-17, with trial results expected in spring. This new study will be the first time any Covid-19 vaccine has been given to infants. 

Click here to view the original article.